Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies

Author： Wong John B.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.7, 2006-01, pp. : 661-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influenza: Cost of Illness and Considerations in the Economic Evaluation of New and Emerging Therapies

By Cram P.  

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 223-230

Adis International

Access to resources Recommend Favorite

Enteroviral Meningitis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies

By Parasuraman T.V.  

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 3-12

Adis International

Access to resources Recommend Favorite

Cystic Fibrosis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies

By Krauth C.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1001-1024

Adis International

Access to resources Recommend Favorite

Acute Pyelonephritis Among Adults: Cost of Illness and Considerations for the Economic Evaluation of Therapy

By Brown Patricia  

PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. : 1123-1142

Adis International

Access to resources Recommend Favorite

Natural Course, Therapeutic Options and Economic Evaluation of Therapies for Chronic Hepatitis B

By Han Steven-Huy B.  

Drugs, Vol. 66, Iss. 14, 2006-01 ,pp. : 1831-1851

Adis International

Access to resources Recommend Favorite